“…To date, various amyloid inhibitors have been designed for the regulation of Aβ aggregation, such as small molecules, , proteins (peptides), aptamers, , polymers, − and nanomaterials. , Among them, nanomaterials have been widely used for the study of the regulation of amyloid aggregation because of their small particle size, large specific surface area, and easy penetration through the blood–brain barrier (BBB). Commonly used nanomaterials, such as gold particles, , nanoselenium, black phosphorus nanosheets, graphene oxide, molybdenum disulfide, quantum dots, and polymeric nanoparticles, have been reported as nanoinhibitors in modulating amyloid aggregation. Most present effective nanoinhibitors functioned with Aβ through noncovalent interactions, such as π–π stacking, hydrogen bonding, electrostatic attraction, and hydrophobic interactions, for preventing Aβ aggregation and reducing Aβ-related cytotoxicity .…”